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etter to the Editorlotho  gene  polymorphisms  and  their  association
typith sickle  cell disease  pheno
ear Editor,
e  read with great interest the recent review presented by de
ouza Pacheco and Goncalves,1 and we  would like to brieﬂy
eport our experience with Klotho (KL) single nucleotide poly-
orphisms (SNPs) and sickle cell disease (SCD).
SCD presents a phenotypic heterogeneity that has not
een fully elucidated yet. Genetic modiﬁers and environmen-
al effects may account for the different clinical outcomes
bserved. Some genetic modulators of SCD are well known,
owever, they do not explain all the phenotypic variations.2,3
Genetic association studies have tried to elucidate this vari-
bility by evaluating SNPs in genes other than the beta globin
ene. However, these data still need to be validated.2–4
Association between KL SNPs and clinical manifestations
f SCD have been observed, especially related with priapism
nd leg ulcers.5–9 Despite the existence of some data about
his topic, these associations have not been conﬁrmed world-
ide. Thus, we  aimed to study KL SNPs in 109 steady state
CD patients, 74 (68%) with SCA, 10 (9%) with Hemoglobin (Hb)
/beta-thalassemia, and 25 (23%) with Hb SC. The mean age
as 32.6 ± 11.3 years with predominance of females (62.3%).
he patients were followed in the Outpatient Clinics of the
scola Paulista de Medicina, Universidade Federal de São
aulo (UNIFESP), Brazil. The Institutional Ethics Committee
pproved this study and informed consent was obtained. We
tudied the correlation between the rs211234 and rs2249358
NPs and priapism9; and between rs516306 and rs685417
nd leg ulcers.8 The DNA was obtained from peripheral
lood leukocytes using a standard kit (QIAamp DNA minikit,
IAGEN). The rs2249358 and rs516306 SNPs were identiﬁed
y polymerase chain reaction (PCR) followed by digestion
ith restriction enzymes (RFLP), as described before.8,9 The
s2111234 and rs685417 SNPs were identiﬁed by the allele-
peciﬁc oligonucleotide-PCR (ASO-PCR) method. Statistical
nalysis was performed using GraphPad Prism® (San Diego,
A, USA); and differences with a p-value < 0.05 were consid-
red statistically signiﬁcant.
Of the 41 male patients in this study, fourteen (34%) had
 history of priapism, 11 with SCA and 3 with Hb SC. Thees
median age of the patients with priapism was signiﬁcantly
higher than the age of the individuals without this manifes-
tation [32.5 years (range: 25–68) and 27.5 years (range: 20–56),
respectively; p-value = 0.03].
We did not ﬁnd any association between priapism and
rs211234 [p-value = 0.4; Odds Ratio (OR): 2.20; 95% conﬁdence
interval (95% CI): 0.45–10.63] or rs2249358 (p-value = 0.72; OR:
1.50; 95% CI: 0.37–6.08). Our results were similar to Elliot et al.
who did not conﬁrm any association between rs211234 and
priapism.6 However, these results were discordant with the
data of Nolan, who described a signiﬁcant association between
priapism and these SNPs.9 The small number of patients stud-
ied could have inﬂuenced these results.
The frequency of leg ulcers (19%) was signiﬁcantly more
frequent in males than females (29.2% vs. 13.2% respectively,
p-value = 0.047). Regarding the genotype, 20 (95%) patients
were diagnosed as SCA and one (5%) as Hb SC.
A previous study about KL SNPs and leg ulcers reported an
association.8 Nevertheless, we did not ﬁnd any association
between rs516306 (p-value = 0.29; OR: 2.19 95% CI: 0.67–7.12)
or rs685417 (p-value = 1.00; OR: 0.95; 95% CI: 0.33–2.73) and leg
ulcers.
Although we did not conﬁrm any relationship between KL
SNPs and clinical manifestations, the importance of these
SNPs in SCD needs to be better elucidated. Given the rele-
vance of this gene, as highlighted by de Souza Pacheco and
Goncalves,1 we believe that more  research is needed to clarify
this association.
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